Lifeboat Foundation

Many of us would love to have a baby, some of us even two or three. But what about having seven of them? It might sound manageable, but now think about having all seven of them at the same time. In the age of medical innovation, fertility treatment has aided many women in getting pregnant. This is the story of a couple who couldn’t have a baby, and then had seven. The years have passed, and now those little septuplets are young adults, making them the oldest surviving septuplets. What a journey it has been for the McCaughey family.

It seems natural to have a baby, and recently it has become natural to take advantage of medical innovation to help you get there. In the case of women who can’t fall pregnant, there are some different methods of getting there. Fertility treatment isn’t uncommon and it is practiced in many countries across the globe. Even though it is an accepted method in many places, there are those that aren’t in favor of it. Some religious groups believe that it is against God’s will to interfere with the natural course of creating life. Their claim is that if God wants to give life he will, and if it is not meant to be then it will not materialize.

Three dozen adults who were all aged 60 or above were asked to take part a range of cognitive tests for the study.

Researchers led by a team based at the National University of Singapore also took MRI scans of the volunteers.

All of the participants, from Singapore, were also asked about how often they drink green, black or oolong tea, as well as coffee.

Amazing 100% I hope it is real and next we can detect more diseases easier and more accurate.

Doctors can detect heart failure from a single heartbeat with 100% accuracy using a new artificial intelligence-driven neural network.

That’s according to a recent study published in Biomedical Signal Processing and Control Journal, which explores how emerging technology can improve existing methods of detecting congestive heart failure.

Continue reading “Artificial Intelligence Detects Heart Failure From One Heartbeat With 100% Accuracy” »

Young blood not required

New technological devices are prioritizing non-invasive tracking of vital signs, not only for fitness monitoring, but also for the prevention of common health problems such as heart failure, hypertension and stress-related complications, among others. Wearables based on optical detection mechanisms are proving an invaluable approach for reporting on our bodies inner workings and have experienced a large penetration into the consumer market in recent years. Current wearable technologies, based on non-flexible components, do not deliver the desired accuracy and can only monitor a limited number of vital signs. To tackle this problem, conformable non-invasive optical-based sensors that can measure a broader set of vital signs are at the top of the end-users’ wish list.

In a recent study published in Science Advances, ICFO researchers have demonstrated a new class of flexible and transparent wearable devices that are conformable to the skin and can provide continuous and accurate measurements of multiple human vital signs. These devices can measure heart rate, respiration rate and blood pulse oxygenation, as well as exposure to UV radiation from the sun. While the device measures the different parameters, the read-out is visualized and stored on a mobile phone interface connected to the wearable via Bluetooth. In addition, the device can operate battery-free since it is charged wirelessly through the phone.

“It was very important for us to demonstrate the wide range of potential applications for our advanced light sensing technology through the creation of various prototypes, including the flexible and transparent bracelet, the health patch integrated on a mobile phone and the UV monitoring patch for sun exposure. They have shown to be versatile and efficient due to these unique features,” reports Dr. Emre Ozan Polat, first author of this publication.

Recent genome-wide association studies have catapulted the search for genes underlying human intelligence into a new era. Genome-wide polygenic scores promise to transform research on individual differences in intelligence, but not without societal and ethical implications, as the authors discuss in this Review.

Cryotechnology has been used in treating lung cancer for many years, now it is emerging to have a new indication in diagnosing lung diseases. Cryoprobe transbronchial lung biopsy has been introduced into clinical practice as a new technique, providing a larger biopsy specimen, potentially improving the diagnostic yield of transbronchial biopsies in parenchymal lung diseases. Although recent small pilot studies suggest that cryotransbronchial lung biopsies are comparable to conventional transbronchial biopsies in terms of diagnostic yield and safety profile in lung transplant patients, cryoprobe transbronchial lung biopsy is still being evaluated and its role in clinical practice is not well defined. Cryotherapy has been proven as a safe and effective method to debulk endobronchial lesions, providing palliation for advanced central obstructive tumors. Its use and efficacy is also studied in direct cryosurgery and percutaneous application in lung cancer. Cryoprobes can also be used to extract foreign bodies from the airways by causing cryoadhesion. We aim to summarize the therapeutic and diagnostic application of cryotechnology in pulmonary diseases.

Ischemic stroke is a condition in which parts of the brain lose their blood supply, causing nerve damage. Once brain tissue suffers irreparable harm, the patient will experience irreversible disability or death, depending on the extent of neuronal loss. However, glial cells surrounding the neurons are activated by the injury and multiply. Now, scientists have found out how to insert genes into glial cells to convert them into neurons, thus filling in for some of the lost functioning cells to improve motor functions.

There are about 86 billion neurons in the brain, but billions of them can be lost with one moderate-sized stroke. About 800,000 new strokes occur each year in the US alone. The need is to regenerate new brain cells to replace the ones that die, at least partially. This is the only known way to restore motor functions that have been impaired or destroyed by a stroke or other brain injury.

Heartburn drug Zantac has been found to be contaminated with low levels of a cancer-linked chemical. This is the same contaminant that lead to multiple recalls of blood pressure drugs.